Kenya Pharmaceuticals & Healthcare Report Q2 2015 - New Market Report

Boston, MA -- (ReleaseWire) -- 01/30/2015 -- The impending dual epidemic of communicable and non-communicable diseases in Kenya will create business opportunities for multinational drugmakers. Investment into physician and patient education and therefore addressing one of the barriers to high-quality care in an emerging economy such as Kenya - will work to indirectly create a sales channel for their medicines, in both the public and private sector. Furthermore, efforts to raise awareness of therapeutics and disease management will work to create patient and prescriber loyalty and build trust for therapeutics for the treatment of 'new' diseases.